There are no stupid questions – only honest ones.
We invented this series because medicine should be explainable. Growing up, my mother always told dentists to explain what they were about to do. And you know what? It worked. Questions reduce fear. They build trust. A good doctor knows that.
In clinical research, one term comes up a lot — early phase. But what does “early phase” actually mean? And is there such a thing as a “late phase” in the end?
Great question. Let’s break it down.
Clinical trials usually follow four official phases:
Phase I: Safety and Dose First-in-human tests (20–80 people) focused on safety and finding the right dose. Participants are often healthy volunteers, but in fields like cancer research, where the treatment may be highly toxic, patients are involved from the start.
Phase II: Efficacy and Side Effects A few hundred patients with the condition receive the drug to see if it works (efficacy) and to track common side effects.
Phase III: Confirmation and Comparison Large-scale trials with thousands of patients compare the new treatment to existing ones (the Standard of Care). This phase confirms whether the drug really helps and provides the necessary data for regulatory approval.
Phase IV: Post-Approval Monitoring After the drug is approved and available to the public, long-term studies continue to check safety and effectiveness in everyday life.
When we say “early phase”, we usually mean Phase I, sometimes Phase II — the part where we’re still figuring out if the treatment is safe and effective. “Late phase” (while not official) typically refers to Phase III and IV, which are the big, confirmatory studies.
In Germany, things are especially strict. Every clinical study here must be approved by an independent Ethics Committee and one of the country’s two regulatory authorities: the Paul-Ehrlich-Institut (PEI) for vaccines and biologicals, or the BfArM (Federal Institute for Drugs and Medical Devices) for other drugs. This two-step greenlight ensures that participants are protected before a study can even begin.
That’s it for today. See you again in Not-So-Stupid Questions.
